Pharmabiz

Apollo Athenaa to aid women’s cancer care with India’s first integrated gynae-oncology & robotic surgery ecosystem

Apollo Athenaa to aid women’s cancer care with India’s first integrated gynae-oncology & robotic surgery ecosystem: Our Bureau, Bengaluru Tuesday, April 28, 2026, 17:40 Hrs [I ...
Pharmabiz

US FDA grants marketing authorization to Essilor Stellest as the spectacle lens for myopia control in India

US FDA grants marketing authorization to Essilor Stellest as the spectacle lens for myopia control in India: Our Bureau, Bengaluru Tuesday, April 28, 2026, 17:30 Hrs [IST] Essilor ...
Pharmabiz

Ascletis Pharma completes enrollment in US phase II study of ASC30 for the treatment of type 2 diabetes mellitus

Ascletis Pharma completes enrollment in US phase II study of ASC30 for the treatment of type 2 diabetes mellitus: Hong Kong Tuesday, April 28, 2026, 13:00 Hrs [IST] Ascletis Pharm ...
Pharmabiz

Jazz Pharma announces US FDA acceptance and priority review of sBLAS for Ziihera combinations in first-line HER2+ locally advanced or metastatic GEA

Jazz Pharma announces US FDA acceptance and priority review of sBLAS for Ziihera combinations in first-line HER2+ locally advanced or metastatic GEA: Dublin Tuesday, April 28, 202 ...
Pharmabiz

Lilly to buy biopharma company Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera

Lilly to buy biopharma company Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera: Indianapolis Tuesday, April 28, 2026, 14:00 Hrs [IST] E ...
Pharmabiz

India's mental health treatment gap hits 92% - Maarga Mind Care launches Integrative Day Care Programme to bridge the gap

India's mental health treatment gap hits 92% - Maarga Mind Care launches Integrative Day Care Programme to bridge the gap: Our Bureau, Bengaluru Tuesday, April 28, 2026, 17:10 Hrs ...
Pharmabiz

US FDA grants priority review for Johnson & Johnson Imaavy as the potential first approved treatment for people living with wAIHA

US FDA grants priority review for Johnson & Johnson Imaavy as the potential first approved treatment for people living with wAIHA: Spring House, Pennsylvania Tuesday, April 28, 20 ...
Pharmabiz

Pune Eyecon 2026 brings together domestic and global ophthalmologists to discuss retinal care advancements

Pune Eyecon 2026 brings together domestic and global ophthalmologists to discuss retinal care advancements: Our Bureau, Bengaluru Tuesday, April 28, 2026, 11:30 Hrs [IST] NIO Supe ...
Pharmabiz

Fortis Gurugram unveils ‘Genomic 360 Wellness Programme’ to transform individual health outcomes

Fortis Gurugram unveils ‘Genomic 360 Wellness Programme’ to transform individual health outcomes: Our Bureau, Bengaluru Tuesday, April 28, 2026, 11:45 Hrs [IST] Fortis Memoria ...
Pharmabiz

IMG Pharma inks agreement to buy Japanese pharma manufacturer, Matsumoto Pharmaceutical

IMG Pharma inks agreement to buy Japanese pharma manufacturer, Matsumoto Pharmaceutical: Tokyo Tuesday, April 28, 2026, 16:00 Hrs [IST] IMG Pharmaceutical Co., Ltd. (IMG Pharma), ...
Pharmabiz

AstraZeneca’s Saphnelo approved in US for subcutaneous self-administration as a new autoinjector to treat systemic lupus erythematosus

AstraZeneca’s Saphnelo approved in US for subcutaneous self-administration as a new autoinjector to treat systemic lupus erythematosus: Cambridge, UK Tuesday, April 28, 2026, 10 ...
Opinion
PharmabizOpinion

Swasti Health Catalyst says India’s digital future hinges on reproductive health tech autonomy

Swasti Health Catalyst says India’s digital future hinges on reproductive health tech autonomy: Our Bureau, Bengaluru Tuesday, April 28, 2026, 17:50 Hrs [IST] Swasti Health Cata ...